🇺🇸 FDA
Patent

US 7615227

Use of CpG oligodeoxynucleotides to induce angiogenesis

granted A61KA61K31/711A61P

Quick answer

US patent 7615227 (Use of CpG oligodeoxynucleotides to induce angiogenesis) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Nov 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/711, A61P, A61P9/00